awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36414417-1D3D81A7-AACF-4BD9-A012-C56E7C074D58
Q36414417-1D3D81A7-AACF-4BD9-A012-C56E7C074D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36414417-1D3D81A7-AACF-4BD9-A012-C56E7C074D58
Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.
P2860
Q36414417-1D3D81A7-AACF-4BD9-A012-C56E7C074D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36414417-1D3D81A7-AACF-4BD9-A012-C56E7C074D58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43bb14a7ea78069a6a6a9095627101831ff856e5
P2860
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.